Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$653,992
-$68,973 QoQ
Shares Held
4,173
-11.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#774
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Greenspring Advisors, LLC holds $12,307,212 across 8 Drug Manufacturers - General names. NVS ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,171 | $3,803,392 | |
| 2 | AMGN |
Amgen Inc
|
6,730 | $2,437,067 | |
| 3 | JNJ |
Johnson & Johnson
|
8,433 | $2,141,729 | |
| 4 | ABBV |
AbbVie Inc.
|
6,143 | $1,545,824 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,857 | $1,009,624 | |
| 6 | NVS |
Novartis AG
This page
|
4,173 | $653,992 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,135 | $396,075 | |
| 8 | AZN |
Astrazeneca PLC
|
1,685 | $319,509 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $653,992 | 4,173 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $722,965 | 4,733 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $592,289 | 4,296 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||